Evogene Ltd EVGN:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 03/28/24 EDT
0.75quote price arrow up+0.0148 (+2.0131%)
Volume
58,555
52 week range
0.45 - 1.44
Loading...
  • Open0.7282
  • Day High0.7699
  • Day Low0.7282
  • Prev Close0.7352
  • 52 Week High1.44
  • 52 Week High Date07/13/23
  • 52 Week Low0.45
  • 52 Week Low Date10/24/23

Key Stats

  • Market Cap37.912M
  • Shares Out50.55M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.48
  • YTD % Change-10.71

KEY STATS

  • Open0.7282
  • Day High0.7699
  • Day Low0.7282
  • Prev Close0.7352
  • 52 Week High1.44
  • 52 Week High Date07/13/23
  • 52 Week Low0.45
  • 52 Week Low Date10/24/23
  • Market Cap37.912M
  • Shares Out50.55M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.48
  • YTD % Change-10.71

RATIOS/PROFITABILITY

  • EPS (TTM)-0.53
  • P/E (TTM)-1.41
  • Fwd P/E (NTM)-1.67
  • EBITDA (TTM)-23.896M
  • ROE (TTM)-119.45%
  • Revenue (TTM)5.64M
  • Gross Margin (TTM)70.00%
  • Net Margin (TTM)-460.18%
  • Debt To Equity (MRQ)95.46%

EVENTS

  • Earnings Date05/23/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Evogene Ltd

 

Profile

MORE
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components...
Sarit Firon
Independent Chairman of the Board
Ofer Haviv
President, Chief Executive Officer
Dorit Kreiner
Chief Financial Officer
Mark Kapel
Executive Vice President - Technology
Sassi Masliah
Executive Vice President - Corporate Development
Address
13 Gad Feinstein Street, Park Rehovot
Rehovot
7638517
Israel